As the volume and complexity of scientific and regulatory data grows, AI has become a critical enabler of smarter, faster decision-making across preclinical, clinical, and regulatory affairs workflows.
Join us for a focused webinar exploring how PharmaPendium AI is advancing drug development by empowering pharmaceutical and biotech teams with rapid, data-driven insights.
This session will showcase how PharmaPendium AI leverages regulatory grade content including FDA Approval packages and advisory committee, EMA EPARs and machine learning to streamline research, enhance regulatory strategies, and reduce regulatory cycling. Whether you're designing studies, evaluating safety signals, or preparing regulatory submissions, learn how PharmaPendium AI can transform your approach to pharmaceutical R&D.
Can't attend live? Sign up and we'll send a link so you can watch the recording.
When?
Tuesday, September 23, 2025 · 10:00 a.m.
Berlin
Duration: 1 hour
Price
Free
Language
English
Who can attend
Everyone
Dial-in available? (listen only)
Not available.
Agenda
Industry challenges in drug development and regulatory science
PharmaPendium AI in action
Key use cases and benefits supporting regulatory strategies
Managing Director, Life Sciences Solutions, Elsevier
Mirit Eldor is Managing Director, Life Sciences Solutions at Elsevier. Mirit is responsible for developing and enabling the execution of Elsevier’s strategy, and spends much of her time looking at new ways to bring together content, data,...
Thomas Vargues is a Senior Product Manager at PharmaPendium, an Elsevier digital platform focused on regulatory information for the pharmaceutical industry. Thomas Vargues holds a PhD in biochemistry. In his role, he leads the development and...